NGL Fine-Chem Limited — Board Meeting, 07-02-2025: Outcome of Board Meeting
07-02-2025 | 07:29 pm
07-02-2025 | 07:29 pm
NGL Fine-Chem Limited has approved the unaudited financial results for the quarter and nine months ended December 31, 2024, during its recent board meeting. The consolidated revenue stood at approximately ₹25.38 crore, while net profit for the period was around ₹8.77 crore. This marks a financial performance improvement compared to the previous year, indicating growth in operations. The results, accompanied by a limited review report from statutory auditors, reflect the company’s ongoing commitment to its pharmaceutical manufacturing business.
No comments yet. Be the first to comment!
